You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -30.6% | -12.6% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -7.2 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 2.5 | 1.9 |
Price / Book value | 5.2 |
Latest | Forecast | |
---|---|---|
Revenue | 43.8% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-12-31 | 87.73 | -6.57 | -7.81p | -131.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 142.80 | 19.88 | 22.77p | 54.0 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 139.99 | -45.98 | -41.29p | -10.7 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 89.54 | -188.53 | -163.11p | -1.3 | 0.0 | n/a | n/a | 0.0% |
2024-12-31 | 128.80 | -47.26 | -41.75p | -10.1 | 0.0 | n/a | n/a | 0.0% |
Oxford Biomedica reports first-half revenue growth Sharecast News | 23 Sep |
---|---|
Oxford Biomedica still expecting small loss after solid first half Sharecast News | 08 Aug |
Oxford Biomedica appoints new finance chief Sharecast News | 17 Jul |
Holding(s) in Company | 23-Apr-25 23:03 |
---|---|
Preliminary results for the year ended 31 Dec 2024 | 09-Apr-25 07:02 |
Holding(s) in Company | 04-Apr-25 08:52 |
OXB Total Voting Rights | 01-Apr-25 07:01 |
Director Declaration | 27-Mar-25 16:45 |